LLYはダメか。PFEは良かったみたいね

$LLY - Eli Lilly Non-GAAP EPS of $2.04 beats by $0.11, revenue of $6.94B beats by $30M, cuts FY22 outlook

$PFE beats the Estimize EPS Consensus by 26c and the Estimize Revenue Consensus by $705.84M. Reports FQ3 earnings of $1.78 EPS and $22.64B Revs